Report cover image

Solubility Enhancement Excipients Market by Product (Particle Size Reduction, Solid Dispersion), Type (Lipid, Polymer, Surfactant), Application - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 193 Pages
SKU # IRE18452849

Description

Solubility Enhancement Excipients Market by Product (Particle Size Reduction, Solid Dispersion), Type (Lipid, Polymer, Surfactant), Application - Global Forecast 2024-2030


The Solubility Enhancement Excipients Market size was estimated at USD 3.63 billion in 2023 and expected to reach USD 3.82 billion in 2024, at a CAGR 5.62% to reach USD 5.33 billion by 2030.

Global Solubility Enhancement Excipients Market

Solubility enhancement excipients are a specific category of pharmaceutical ingredients used primarily in the drug manufacturing process to increase the solubility of poorly soluble drug compounds. They play a critical role in bioavailability enhancement, facilitating the dissolution of drugs into the body and thus increasing their therapeutic effectiveness. The rise in chronic diseases and increase in drug discovery and development are accelerating the need for solubility enhancement excipients from the pharmaceutical industries. However, volatility in raw material cost and stringent regulations may adversely impact the use of solubility enhancement excipients by the end-use sectors. Moreover, the proliferation of nanotechnology, the incorporation of bio-based excipients, and the development of multifunctional excipients are expected to create immense potential for the growth of solubility enhancement excipients worldwide.

Regional Insights

The solubility enhancement excipients market is evolving in the Americas owing to the well-established pharmaceutical industries, innovations in drug formulation, and technological advancements in drug manufacturing. The Asia Pacific is witnessing significant demand for solubility enhancement excipients due to the increasing prevalence of chronic diseases, the surge in research and development activities, and high generic drug production. Europe, Middle East, and Africa (EMEA) represent high demand for solubility enhancement excipients with strong research and development foundations, ongoing development of novel excipients used in oral administration, and expanding healthcare infrastructure. Besides, technological advancements in the manufacturing of solubility enhancement excipients and ongoing research to improve their properties are anticipated to expand the use of solubility enhancement excipients across the end-use sectors globally.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Solubility Enhancement Excipients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Solubility Enhancement Excipients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Solubility Enhancement Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Air Liquide S.A., Ashland Global Holdings Inc., BASF SE, Cargill, Incorporated, Clariant International Ltd., Croda International PLC, DuPont de Nemours Inc., Evonik Industries AG, FMC Corporation, FREUND Corporation, Gattefossé, IMCD Group, JRS Pharma GmbH & Co. KG, Kerry Group PLC, Lubrizol Corporation, Merck KGaA, Nippon Soda Co. Ltd., Pharma Excipients International AG, Roquette Freres SA, Shin-Etsu Chemical Co., Ltd., Solvay SA, SPI Pharma Inc., The DOW Chemical Company, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Solubility Enhancement Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Particle Size Reduction
Solid Dispersion
Type
Lipid
Polymer
Surfactant
Application
Hospitals
Pharmaceuticals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Solubility Enhancement Excipients Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Solubility Enhancement Excipients Market?
3. What are the technology trends and regulatory frameworks in the Solubility Enhancement Excipients Market?
4. What is the market share of the leading vendors in the Solubility Enhancement Excipients Market?
5. Which modes and strategic moves are suitable for entering the Solubility Enhancement Excipients Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

193 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Solubility Enhancement Excipients Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid expansion of pharmaceutical industry globally
5.1.1.2. Rising demand for polymer excipients
5.1.1.3. High adoption of solid dispersion technology and need to increase the bioavailability of the API
5.1.2. Restraints
5.1.2.1. High cost of solubility enhancement excipients
5.1.3. Opportunities
5.1.3.1. Advancements in technology and process analysis for solubility enhancement techniques
5.1.3.2. Novel excipients for solubility enhancement
5.1.4. Challenges
5.1.4.1. Adverse effects associated with the use of excipients
5.2. Market Segmentation Analysis
5.2.1. Product: Consumer preference for particle size reduction as it provides improved drug loading efficiency
5.2.2. Type: Extensive utilization of surfactants as solubility enhancement excipients to develop surfactant-based drug delivery systems
5.2.3. Application: Significant role of solubility enhancement excipients in the pharmaceutical field to drive product excellence
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Solubility Enhancement Excipients Market, by Product
6.1. Introduction
6.2. Particle Size Reduction
6.3. Solid Dispersion
7. Solubility Enhancement Excipients Market, by Type
7.1. Introduction
7.2. Lipid
7.3. Polymer
7.4. Surfactant
8. Solubility Enhancement Excipients Market, by Application
8.1. Introduction
8.2. Hospitals
8.3. Pharmaceuticals
9. Americas Solubility Enhancement Excipients Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Solubility Enhancement Excipients Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Solubility Enhancement Excipients Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Hovione and Zerion Pharma Announce a Strategic Partnership to Market the Dispersome Technology Platform
12.3.2. New Product Launch & Enhancement
12.3.2.1. Clariant Launches New Range Of Excipients To Improve Stability and Solubility of APIs at CPHI Barcelona
12.3.2.2. Lubrizol Launches Innovative Apisolex Technology to Improve Solubility & Simplify Manufacturing of Parenteral Drug Products
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. ABITEC Corporation
13.1.2. Air Liquide S.A.
13.1.3. Ashland Global Holdings Inc.
13.1.4. BASF SE
13.1.5. Cargill, Incorporated
13.1.6. Clariant International Ltd.
13.1.7. Croda International PLC
13.1.8. DuPont de Nemours Inc.
13.1.9. Evonik Industries AG
13.1.10. FMC Corporation
13.1.11. FREUND Corporation
13.1.12. Gattefossé
13.1.13. IMCD Group
13.1.14. JRS Pharma GmbH & Co. KG
13.1.15. Kerry Group PLC
13.1.16. Lubrizol Corporation
13.1.17. Merck KGaA
13.1.18. Nippon Soda Co. Ltd.
13.1.19. Pharma Excipients International AG
13.1.20. Roquette Freres SA
13.1.21. Shin-Etsu Chemical Co., Ltd.
13.1.22. Solvay SA
13.1.23. SPI Pharma Inc.
13.1.24. The DOW Chemical Company
13.1.25. Wacker Chemie AG
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET RESEARCH PROCESS
FIGURE 2. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET DYNAMICS
FIGURE 7. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us